RBC Capital analyst Daniel Perlin raised the firm’s price target on Global Payments (GPN) to $139 from $130 and keeps an ...

RBC Capital lowered the firm’s price target on Biogen (BIIB) to $225 from $231 but keeps an Outperform rating on the shares after its Q4 ...

The prospect of a growing trade war isn’t just a risk to Canada’s industries, it also poses a threat to the Canadian housing market, says RBC Economics.

Investing.com -- RBC Capital Markets analysts have expressed a cautious outlook on Smiths Group 's (LON: SMIN) stock, citing limited upside potential despite the company’s decision to pursue a partial ...

RBC was the buyer, beefing up its position in personal and ... “Our investments to strengthen our governance and control structure, core operations and anti-money laundering measures will position us ...

Following the company’s second quarter results, RBC analyst Drew McReynolds has raised his price target on WildBrain.

CNO Financial Group Inc (NYSE:CNO). shares soared to an all-time high this week, reaching a price level of $41.56. With a market capitalization of $4.22 billion and a P/E ratio of 10.88, InvestingPro ...

IN a recent paper, Dervichian, Fournet and Guinier describe experiments on the low-angle scattering of X-rays from red blood cells 1. They show that the scattering curve can be explained as being ...

RBC Capital Markets updated its outlook on Fortive Corporation (NYSE:FTV), a diversified industrial technology conglomerate with a market capitalization of $27.5 billion, by increasing the price ...

RBC Capital analyst Fernando Garcia maintained a Hold rating on Acciona (0H4K – Research Report) today and set a price target of €125.00. The ...

In the pursuit of optimal health, the role of vitamins and minerals often plays a seemingly understated yet pivotal part.